EscharEx
AssetAlso EX-03
Bromelain-based proteolytic enzymes remove devitalized tissue from chronic wounds through enzymatic debridement.
- Stage
- Phase 2
- Modality
- Protein or enzyme
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Venus leg ulcers
Phase 2, Not yet recruiting, NCT06690177, clinicaltrials.gov, 15 Oct 2026
In the full profile
- Owner and partners1
- Trials1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.